Hillstream BioPharma, Inc.
News
Hillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly Anderson
Globe Newswire Appointment to Enhance Boards ExpertiseAcross Investments, Business Development and Capital Markets\n Kelly Anderson\n\n Hillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly Anderson\n\nBRIDGEWATER, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: ...\n more…
Hillstream BioPharma Announces Closing of Public Offering of Common Stock
Globe Newswire BRIDGEWATER, N.J., May 02, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting drug resistant and devastating cancers using ferroptosis, an emerging new anti-cancer mechanism resulting...\n more…
Hillstream BioPharma to Present at Upcoming May 2023 Investor and Industry Conferences
Globe Newswire 12th Drug Discovery Strategic Summit, being held May 3-4 in Boston, MA Sidoti Micro-Cap Virtual Conference, being held virtually on May 10-11 World Orphan Drug Congress, being held May 23-25 in Washington, D.C. BRIDGEWATER, N.J., May 02, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: ...\n more…
Hillstream BioPharma Announces Pricing of Public Offering
Globe Newswire BRIDGEWATER, N.J., April 27, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting drug resistant and devastating cancers using ferroptosis, an emerging new anti-cancer mechanism ...\n more…
Hillstream BioPharma proposes stock and warrants offering, shares fall 20%
Seeking Alpha - Healthcare Hillstream BioPharma (HILS) said Thursday it intends to offer to sell shares of its common stock, and/or pre-funded warrants in an underwritten public offering.\n more…
Hillstream BioPharma Announces Proposed Public Offering
Globe Newswire BRIDGEWATER, N.J., April 27, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting drug resistant and devastating cancers using ferroptosis, an emerging new anti-cancer mechanism ...\n more…